The company’s peak sales forecast of more than $500 million remains unchanged
News
Gov unveils new anti-obesity measures
The move follows research highlighting the negative impact of obesity on COVID-19 survival
People at high risk of diabetes fast-tracked into prevention programme
The move follows research showing that severe obesity can double the risk of dying from COVID-19
Eleven medicines backed for EU approval
Recommendations include the first antibody-drug conjugate for multiple myeloma patients with limited treatment options
AZ’ COPD therapy wins US approval
Breztri Aerosphere is also under regulatory review in the EU
PharmaTimes competitions go virtual!
The online judging process will highlight the successful way entrants have adapted to a lockdown business model
BioMarin submits EU marketing application for vosoritide
If approved, vosoritide would be the first medicine for the treatment of achondroplasia – the most common form of short stature – in Europe
Gov unveils plans to boost UK’s vaccines manufacturing capabilities
New state-of-the-art centre to scale up COVID-19 vaccine and gene therapy manufacturing gets £100 million investment
Lords urge government to act to now avert winter COVID-19 spike
The House of Lords Science and Technology Committee has written to the prime minister with recommendations for dampening the expected surge in cases
Patient Partnership Index 2020 – results announced!
The Index showcases excellence in patient partnerships and establishes the benchmark for how they can be created and delivered
UCL start-up Novai raises £500,000 for AI tech
The funds will be used to further developed tech that enables earlier detection of eye disease
End of the line for Genfit’s experimental NASH drug
Development of elafibranor will be discontinued for NASH, with the company now focusing on its future as a treatment for PBC
COVID-19 more severe in colder months, research suggests
Findings “paint a grim picture” for this winter, the researchers warn
Vertex and NHS Wales agree on Kaftrio reimbursement
The letter of intent should secure access to the combination for people with cystic fibrosis upon its regulatory approval
Roche partners with Jnana on SLC transporters
The aggregate value of future payments to Jnana could overshoot $1 billion
